HIV / AIDS in the News

Cincinnati debates needle exchange program amid HIV concerns and opposition - FOX19 | Cincinnati

 

DoxyPEP Prevents Syphilis and Chlamydia in Real-World Studies - POZ

 

FDA Expands Label of Oral HIV Drug to Newborns - MedPage Today

 

FDA approves Tivicay PD for infants and children with HIV weighing at least 2 kg - Managed Healthcare Executive

 

FDA Expands Dolutegravir Approval to Infants With HIV-1 Weighing at Least 2 kg - Patient Care Online

 

HIV-positive Unionville man charged with 3 felonies including sodomy - KTVO

 

Newborns with HIV Can Now Get a Second Generation Antiviral from Birth Under a Newly Expanded Federal Label - Medical Daily

 

Kuwait Study Measures Hepatitis B, C, HIV in People Who Inject Drugs - Bioengineer.org

 

HIV and Self-Advocacy in a Medical Setting: How to Overcome Institutional Stigma - Everyday Health

 

HIV Prevention Injection | CDSCO Exempts Dr Reddy's And Mcure Pharmaceuticals From Phase 3 Clinical Trials - ETV Bharat

 

Govt targets HIV, Teenage Pregnancies in youth health push - Capital FM Africa

 

LIVE! — HE SAID, HE SAID, HE SAID — “The Next Chapter in Living with HIV” — FRI. 8.28.26 7PM EST - BlackPressUSA

 

FDA Approves Tivicay PD for Infants With HIV - Contagion Live

 

FDA greenlights ViiV’s Tivicay PD for HIV-positive newborns in first month of life - drugdiscoverytrends.com

 

FDA Approves Tivicay PD to Treat HIV Infection in Newborns - Drug Topics

 

FDA Expands Tivicay PD Indication to Newborns - Infectious Disease Special Edition

 

Kelly Rowland to Headline AIDS Walk Atlanta 2026 as Positive Impact Health Centers Joins Beneficiary Roster - Gaye Magazine

 

GSK's ViiV Healthcare Says US FDA Approves Tivicay PD for Pediatric HIV Patients - marketscreener.com

 

Haisco grants license to Sentivera; ViiV’s HIV treatment OK’d for newborns - Endpoints News

 

GSK Looks 14.4% Overvalued on GF Value™ Amid New HIV Treatment A - GuruFocus

 

Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting - The Motley Fool

 

FDA approves Tivicay PD for infants with HIV weighing at least 2 kg - Investing.com India

 

FDA approves Tivicay PD for infants with HIV weighing at least 2 kg - Investing.com UK

 

U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children - Business Wire

 

Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting - Yahoo Finance

 

Laird bill to expand access to HIV prevention medication passes Legislature - Paso Robles Daily News

 

South Dakota sees rise in HIV spread among people who inject drugs - Argus Leader

 

GSK-owned ViiV wins FDA label expansion for HIV drug Tivicay for newborns - Seeking Alpha

 

Pharmacy pilot seeks to reduce HIV transmission - PharmacyToday.co.nz

 

Viiv's dolutegravir nodded by FDA for HIV treatment in newborns - AllSci